Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel

International Journal of Antimicrobial Agents

Volumn 28, Issue 4, 2006, Pages 313-319

  Nir Paz, Ran ^a   Block, Colin ^a   Shasha, David ^a   Korenman, Zinaida ^b   Gorodnitzky, Zeev ^b   Jaffe, Joseph ^a   Ron, Merav ^a   Michael Gayego, Ayelet ^a   Cohen Poradosu, Ronit ^a   Shapiro, Mervyn ^a   Moses, Allon E ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

Author keywords

Antibiotic susceptibility; emm typing; Streptococcus pyogenes

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; GENOTYPE; HUMAN; ISRAEL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STREPTOCOCCUS PYOGENES; TIME SERIES ANALYSIS;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; ISRAEL; LINCOSAMIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TETRACYCLINE;

EID: 33748743886     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.07.005     Document Type: Article

References (48)

1. Carapetis J.R., Steer A.C., Mulholland E.K., and Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 5 (2005) 685-694
2. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 34 (2002) 482-492
3. Huovinen P. Macrolide-resistant group a streptococcus-now in the United States. N Engl J Med 346 (2002) 1243-1245
4. Martin J.M., Green M., Barbadora K.A., and Wald E.R. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med 346 (2002) 1200-1206
5. Giovanetti E., Brenciani A., Lupidi R., Roberts M.C., and Varaldo P.E. Presence of the tet(O) gene in erythromycin- and tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the mef(A) or the erm(A) gene. Antimicrob Agents Chemother 47 (2003) 2844-2849
6. Silva-Costa C., Ramirez M., and Melo-Cristino J. Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal. Antimicrob Agents Chemother 49 (2005) 2109-2111
7. Martel A., Decostere A., Leener E.D., et al. Comparison and transferability of the erm(B) genes between human and farm animal streptococci. Microb Drug Resist 11 (2005) 295-302
8. Giovanetti E., Brenciani A., Vecchi M., Manzin A., and Varaldo P.E. Prophage association of mef(A) elements encoding efflux-mediated erythromycin resistance in Streptococcus pyogenes. J Antimicrob Chemother 55 (2005) 445-451
9. Brenciani A., Ojo K.K., Monachetti A., et al. Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance. J Antimicrob Chemother 54 (2004) 991-998
10. Gattringer R., Sauermann R., Lagler H., et al. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary. Int J Antimicrob Agents 24 (2004) 290-293
11. Szczypa K., Sadowy E., Izdebski R., and Hryniewicz W. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J Antimicrob Chemother 54 (2004) 828-831
12. Katz K.C., McGeer A.J., Duncan C.L., et al. Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001. Antimicrob Agents Chemother 47 (2003) 2370-2372
13. Reinert R.R., Lutticken R., Bryskier A., and Al-Lahham A. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob Agents Chemother 47 (2003) 489-493
14. Zampaloni C., Cappelletti P., Prenna M., Vitali L.A., and Ripa S. emm gene distribution among erythromycin-resistant and -susceptible Italian isolates of Streptococcus pyogenes. J Clin Microbiol 41 (2003) 1307-1310
15. d'Oliveira R.E., Barros R.R., Mendonca C.R., Teixeira L.M., and Castro A.C. Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro, Brazil. Microb Drug Resist 9 (2003) 87-91
16. Malbruny B., Nagai K., Coquemont M., et al. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J Antimicrob Chemother 49 (2002) 935-939
17. Matsumoto M., Sakae K., Ohta M., et al. Molecular mechanisms of high level tetracycline-resistance in group A streptococcal isolates, T serotypes 4 and 11. Int J Antimicrob Agents 25 (2005) 142-147
18. Nishimoto Y., Kobayashi N., Alam M.M., Ishino M., Uehara N., and Watanabe N. Analysis of the prevalence of tetracycline resistance genes in clinical isolates of Enterococcus faecalis and Enterococcus faecium in a Japanese hospital. Microb Drug Resist 11 (2005) 146-153
19. De Leener E., Martel A., Decostere A., and Haesebrouck F. Distribution of the erm(B) gene, tetracycline resistance genes, and Tn1545-like transposons in macrolide- and lincosamide-resistant enterococci from pigs and humans. Microb Drug Resist 10 (2004) 341-345
20. Hammerum A.M., Nielsen H.U., Agerso Y., Ekelund K., and Frimodt-Moller N. Detection of tet(M), tet(O) and tet(S) in tetracycline/minocycline-resistant Streptococcus pyogenes bacteraemia isolates. J Antimicrob Chemother 53 (2004) 118-119
21. Nielsen H.U., Hammerum A.M., Ekelund K., Bang D., Pallesen L.V., and Frimodt-Moller N. Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes?. Microb Drug Resist 10 (2004) 231-238
22. Montanari M.P., Cochetti I., Mingoia M., and Varaldo P.E. Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 47 (2003) 2236-2241
23. Clermont D., Chesneau O., De Cespedes G., and Horaud T. New tetracycline resistance determinants coding for ribosomal protection in streptococci and nucleotide sequence of tet(T) isolated from Streptococcus pyogenes A498. Antimicrob Agents Chemother 41 (1997) 112-116
24. Lowbury E.J., and Hurst L. Atypical anaerobic forms of Streptococcus pyogenes associated with tetracycline resistance. J Clin Pathol 9 (1956) 59-65
25. Jasir A., Tanna A., Efstratiou A., and Schalen C. Unusual occurrence of M type 77, antibiotic-resistant group A streptococci in southern Sweden. J Clin Microbiol 39 (2001) 586-590
26. Jasir A., Tanna A., Noorani A., Mirsalehian A., Efstratiou A., and Schalen C. High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study. J Clin Microbiol 38 (2000) 2103-2107
27. Kataja J., Huovinen P., Efstratiou A., Perez-Trallero E., and Seppala H. Clonal relationships among isolates of erythromycin-resistant Streptococcus pyogenes of different geographical origin. Eur J Clin Microbiol Infect Dis 21 (2002) 589-595
28. Facinelli B., Spinaci C., Magi G., Giovanetti E., and Varaldo P. Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 358 (2001) 30-33
29. Moses A.E., Goldberg S., Korenman Z., Ravins M., Hanski E., and Shapiro M. Invasive group a streptococcal infections, Israel. Emerg Infect Dis 8 (2002) 421-426
30. Moses A.E., Hidalgo-Grass C., Dan-Goor M., et al. emm typing of M nontypeable invasive group A streptococcal isolates in Israel. J Clin Microbiol 41 (2003) 4655-4659
31. Beall B., Facklam R., and Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 34 (1996) 953-958
32. Johnson D.R., and Kaplan E.L. A review of the correlation of T-agglutination patterns and M-protein typing and opacity factor production in the identification of group A streptococci. J Med Microbiol 38 (1993) 311-315
33. Johnson D.R., Kaplan E.L., VanGheem A., Facklam R.R., and Beall B. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J Med Microbiol 55 (2006) 157-164
34. Seppala H., Nissinen A., Yu Q., and Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 32 (1993) 885-891
35. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth Informational Supplement. Document M100-S15. Wayne, PA: CLSI; 2005.
36. Giovanetti E., Montanari M.P., Mingoia M., and Varaldo P.E. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains. Antimicrob Agents Chemother 43 (1999) 1935-1940
37. Aminov R.I., Garrigues-Jeanjean N., and Mackie R.I. Molecular ecology of tetracycline resistance: development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins. Appl Environ Microbiol 67 (2001) 22-32
38. Horn D.L., Zabriskie J.B., Austrian R., et al. Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis 26 (1998) 1341-1345
39. Seppala H., Klaukka T., Vuopio-Varkila J., et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 337 (1997) 441-446
40. Barkai G., Greenberg D., Givon-Lavi N., Dreifuss E., Vardy D., and Dagan R. Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis 11 (2005) 829-837
41. Weiss I., Gorodnitzky Z., Korenman Z., and Yagupsky P. Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel. Eur J Clin Microbiol Infect Dis 16 (1997) 20-23
42. Akata F., Ozturk D., Tansel O., et al. Resistance to macrolides in Group A streptococci from the European section of Turkey: genetic and phenotypic characterization. Int J Antimicrob Agents 20 (2002) 461-463
43. Chopra I., and Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65 (2001) 232-260 second page, table of contents
44. Kanellopoulou M., Makri A., Damaskopoulou H., and Malamou-Lada H. Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens. Clin Microbiol Infect 6 (2000) 653-656
45. Cha S., Lee H., Lee K., Hwang K., Bae S., and Lee Y. The emergence of erythromycin-resistant Streptococcus pyogenes in Seoul, Korea. J Infect Chemother 7 (2001) 81-86
46. Maruyama S., Yoshioka H., Fujita K., Takimoto M., and Satake Y. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am J Dis Child 133 (1979) 1143-1145
47. Jasir A., and Schalen C. Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes. J Antimicrob Chemother 41 (1998) 135-137
48. Perez-Trallero E., Marimon J.M., Montes M., Orden B., and de Pablos M. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg Infect Dis 5 (1999) 235-240